Valuation Vanda Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 20:00:00 10/03/2026 GMT			After hours 21:34:07
9.560 ^USD	+10.14%		9.710	+1.57%

03-05	Truist Initiates Vanda Pharmaceuticals at Buy With $18 Price Target	MT
03-05	Vanda Pharmaceuticals Insider Sold Shares Worth $1,276,971, According to a Recent SEC Filing	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	874.1	418.2	242.8	279.3	521.2	513.1	-	-
Change	-	-52.16%	-41.95%	15.04%	86.62%	-1.57%	-	-
Enterprise Value (EV) ¹	874.1	418.2	242.8	279.3	521.2	339.8	352	513.1
Change	-	-52.16%	-41.95%	15.04%	86.62%	-34.8%	3.57%	45.76%
P/E ratio	27.1x	67.2x	106x	-14.5x	-2.36x	-3.88x	-11x	200x
PBR	-	-	-	-	-	2.31x	2.76x	-
PEG	-	-0.8x	-1.7x	0x	-0x	0.1x	0.2x	-2x
Capitalization / Revenue	3.25x	1.64x	1.26x	1.41x	2.41x	2x	1.45x	1.13x
EV / Revenue	3.25x	1.64x	1.26x	1.41x	2.41x	1.32x	1x	1.13x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	20.7x	66.1x	-17.4x	-6.87x	-3.45x	-2.11x	-4.94x	-350x
EV / FCF	-	-	-	-13.6x	-4.72x	-2.55x	-6.66x	68.4x
FCF Yield	-	-	-	-7.33%	-21.2%	-39.3%	-15%	1.46%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.58	0.11	0.04	-0.33	-3.74	-2.236	-0.792	0.0433
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	268.7	254.4	192.6	198.8	216.1	257.1	353.3	453.8
EBITDA	45.01	-	-	-	-	-	-	-
EBIT ¹	42.16	6.329	-13.95	-40.66	-151.2	-160.7	-71.22	-1.467
Net income ¹	33.15	6.275	2.509	-18.9	-220.5	-133.5	-55.5	-1
Net Debt ¹	-	-	-	-	-	-173.2	-161.1	-
Reference price ²	15.690	7.390	4.220	4.790	8.820	8.680	8.680	8.680
Nbr of stocks (in thousands)	55,712	56,590	57,532	58,308	59,097	59,108	-	-
Announcement Date	23/02/22	08/02/23	07/02/24	13/02/25	11/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VANDA PHARMACEUTICALS INC.	-3.88x	1.32x	-	-	513M
ARGENX SE	42.6x	9.96x	35.95x	0.03%	44.74B
WUXI APPTEC CO., LTD.	15.63x	5.59x	12.3x	1.91%	39.46B
INSMED INCORPORATED	-53.22x	17.93x	-59.23x	-.--%	30.85B
BIONTECH SE	-25.8x	4.23x	-11.67x	-.--%	25.64B
WUXI BIOLOGICS (CAYMAN) INC.	27.29x	5.62x	15.61x	-.--%	18.74B
GENMAB A/S	21.64x	4.48x	15.61x	-.--%	16.45B
AKESO, INC.	-298.93x	24.74x	1362.16x	-.--%	12.22B
SUMMIT THERAPEUTICS INC.	-13.89x	6208.56x	-17.75x	-.--%	12.19B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-158.7x	38.79x	-154.09x	-.--%	11.33B
Average	-44.73x	632.12x	133.21x	0.22%	21.21B
Weighted average by Cap.	-21.37x	367.34x	71.79x	0.36%